Clinical Trial

A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects
Protocol Amendment History 2 changes
critical Trial completed 2026-07-16
minor Completion pushed: 2026-06 -> 2026-07-05 2026-07-16
Trial Details
NCT Number NCT07633691
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Healthy Adult
Enrollment 12 participants
Start Date 2026-06-15
Primary Completion 2026-06-23 (estimated)
Study Completion 2026-07-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-15